Surgeon training, protocol compliance, and technical outcomes from breast cancer sentinel lymph node randomized trial

Journal of the National Cancer Institute

Volumn 101, Issue 19, 2009, Pages 1356-1362

  Krag, David N ^a,e   Ashikaga, Takamaru ^a   Harlow, Seth P ^a   Skelly, Joan M ^a   Julian, Thomas B ^b,d   Brown, Ann M ^c   Weaver, Donald L ^a   Wolmark, Norman ^b,d  

^a UNIVERSITY OF VERMONT   (United States)

^b NSABP Foundation Inc   (United States)

^c UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^d ALLEGHENY GENERAL HOSPITAL   (United States)

^e UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER CONTROL; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED STUDY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LABORATORY DIAGNOSIS; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MEDICAL EDUCATION; PRIORITY JOURNAL; SENTINEL LYMPH NODE; TREATMENT OUTCOME;

ADULT; AGED; BREAST NEOPLASMS; EDUCATION, MEDICAL, CONTINUING; FALSE NEGATIVE REACTIONS; FEMALE; GUIDELINE ADHERENCE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MEDICAL AUDIT; MEDICAL RECORDS; MIDDLE AGED; NEOPLASM STAGING; SENTINEL LYMPH NODE BIOPSY;

EID: 70349975595     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djp281     Document Type: Article

References (11)

1. Krag DN, Anderson SJ, Julian TB, et al. Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial. Lancet Oncol. 2007 ; 8 ( 10 ): 881-888.
2. Krag D, Weaver D, Ashikaga T, et al. The sentinel node in breast cancer - a multicenter validation study. N Engl J Med. 1998 ; 339 ( 14 ): 941-946. (Pubitemid 28455095)
3. Harlow SP, Krag DN, Julian TB, et al. Prerandomization Surgical Training for the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-32 trial: a randomized phase III clinical trial to compare sentinel node resection to conventional axillary dissection in clinically node-negative breast cancer. Ann Surg. 2005 ; 241 ( 1 ): 48-54.
4. Conover WJ. Practical Nonparametric Statistic. New York, NY : John Wiley & Sons ; 1971.
5. Begg C, Cho M, Eastwood S, et al. Improving the quality of reporting of randomized controlled trials. The CONSORT statement. JAMA. 1996 ; 276 ( 8 ): 637-639.
6. Kim T, Giuliano AE, Lyman GH. Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma: a metaanalysis. Cancer. 2006 ; 106 ( 1 ): 4-16.
7. You YN, Jacobs L, Martinez ED, et al. Improved surgeon performance in clinical trials: an analysis of quality assurance audits from the American College of Surgeons Oncology Group. J Am Coll Surg. 2006 ; 203 ( 3 ): 269-276.
8. Sasako M. Clinical trials of surgical treatment of malignant diseases. Int J Clin Oncol. 2005 ; 10 ( 3 ): 165-170.
9. Balasubramanian SP, Wiener M, Alshameeri Z, Tiruvoipati R, Elbourne D, Reed MW. Standards of reporting of randomized controlled trials in general surgery: can we do better? Ann Surg. 2006 ; 244 ( 5 ): 663-667. (Pubitemid 44629937)
10. Povoski SP, Young DC, Walker MJ, et al. Re-emphasizing the concept of adequacy of intraoperative assessment of the axillary sentinel lymph nodes for identifying nodal positivity during breast cancer surgery. World J Surg Oncol. 2007 ; 5 : 18.
11. Wong SL, Edwards MJ, Chao C, et al. Sentinel lymph node biopsy for breast cancer: impact of the number of sentinel nodes removed on the false-negative rate. J Am Coll Surg. 2001 ; 192 ( 6 ): 689-691